Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Microorganisms
|
September 28, 2021
Reply to Schulte-Pelkum, J. Comment on "Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. <i>Microorganisms</i> 2021, <i>9</i>, 556"
Julien Favresse, Constant Gillot, Jonathan Douxfils
The Journal of Infection
|
August 18, 2021
Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ
Jonathan Douxfils, Constant Gillot, François Mullier, et al.
Viruses
|
November 27, 2021
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
Constant Gillot, Julien Favresse, Vincent Maloteau, et al.
Bio-Protocol
|
May 9, 2022
Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells
Constant Gillot, Julien Favresse, Vincent Maloteau, et al.
Clinical Chemistry and Laboratory Medicine
|
August 15, 2024
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
Constant Gillot, Clara David, Jean-Michel Dogné, et al.
Frontiers in Pharmacology
|
August 23, 2021
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
Constant Gillot, Julien Favresse, François Mullier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 7, 2024
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Julien Cabo, et al.
Thrombosis Research
|
May 14, 2026
Techniques for measuring NETosis: A critical literature review and outlook for standardization
Constant Gillot, Hachem Bouarroudj, Jonathan Decarpentrie, et al.
Heliyon
|
January 15, 2025
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study
Marie Didembourg, Clara David, Laure Morimont, et al.
Case Reports in Infectious Diseases
|
September 9, 2024
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population
Constant Gillot, Jean-Louis Bayart, Vincent Maloteau, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Microorganisms
|
September 28, 2021
Reply to Schulte-Pelkum, J. Comment on "Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. <i>Microorganisms</i> 2021, <i>9</i>, 556"
Julien Favresse, Constant Gillot, Jonathan Douxfils
The Journal of Infection
|
August 18, 2021
Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ
Jonathan Douxfils, Constant Gillot, François Mullier, et al.
Viruses
|
November 27, 2021
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
Constant Gillot, Julien Favresse, Vincent Maloteau, et al.
Bio-Protocol
|
May 9, 2022
Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells
Constant Gillot, Julien Favresse, Vincent Maloteau, et al.
Clinical Chemistry and Laboratory Medicine
|
August 15, 2024
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
Constant Gillot, Clara David, Jean-Michel Dogné, et al.
Frontiers in Pharmacology
|
August 23, 2021
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
Constant Gillot, Julien Favresse, François Mullier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 7, 2024
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Julien Cabo, et al.
Thrombosis Research
|
May 14, 2026
Techniques for measuring NETosis: A critical literature review and outlook for standardization
Constant Gillot, Hachem Bouarroudj, Jonathan Decarpentrie, et al.
Heliyon
|
January 15, 2025
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study
Marie Didembourg, Clara David, Laure Morimont, et al.
Case Reports in Infectious Diseases
|
September 9, 2024
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population
Constant Gillot, Jean-Louis Bayart, Vincent Maloteau, et al.
Page
of 4